Screener
Trevi Therapeutics, Inc. TRVI Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by Trevi Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:MarketableSecuritiesCurrent.
The source filing: Trevi Therapeutics, Inc.’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 4:09 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-206390
| Assets | March 31,2026 / Unaudited | December 31,2025 |
|---|---|---|
| Current assets: | ||
| Cash and cash equivalents | $19,412 | $18,914 |
| Marketable securities | 152,371 | 169,346 |
| Prepaid expenses | 2,216 | 1,263 |
| Other current assets | 2,122 | 2,133 |
| Total current assets | 176,121 | 191,656 |
| Operating lease right-of-use assets | 610 | 677 |
| Property, equipment and leasehold improvements, net | 265 | 178 |
Item 1. Condensed Consolidated Financial Statements.
FAQ
- What is Trevi Therapeutics, Inc.'s short-term investments?
- Trevi Therapeutics, Inc. (TRVI) reported short-term investments of $152.37M in Q1 2026.
- How has Trevi Therapeutics, Inc.'s short-term investments changed year-over-year?
- Trevi Therapeutics, Inc.'s short-term investments increased by 81.6% year-over-year, from $83.88M to $152.37M.
- What is the long-term trend for Trevi Therapeutics, Inc.'s short-term investments?
- Over 3 years (2022 to 2025), Trevi Therapeutics, Inc.'s short-term investments has grown at a 16.2% compound annual growth rate (CAGR), from $107.92M to $169.35M.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.
Ask your AI about Trevi Therapeutics, Inc.'s short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude